₹3,067 Cr
--
₹-153 Cr
As on 13-Aug-2024 IST
₹3.01
•
1.56%
₹192.67
₹195.15
₹203.99
₹193.50
11,59,913
₹133.00 - 283.00
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Dishman Carbogen
| 14.47 | 16.12 | -1.62 | 26.08 | -1.72 | -1.08 | -- |
|
BSE Healthcare
| 30.05 | 6.86 | 18.26 | 46.79 | 16.31 | 26.45 | 12.81 |
|
BSE Small Cap
| 24.81 | -1.39 | 17.32 | 50.92 | 26.42 | 33.21 | 18.27 |
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|
|
Dishman Carbogen
| 80.14 | -52.91 | 41.79 | 76.70 | -63.80 | -28.09 |
|
BSE Small Cap
| 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 |
|
BSE Healthcare
| 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 |
|
Stock
|
Peer Median
|
||
|---|---|---|---|
Please wait... |
|||
|
Stock
|
Peer Median
|
||
|---|---|---|---|
Please wait... |
|||
No Review & Analysis are available.
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Dishman Carbogen Amcis Ltd stood at ₹ 9,581 Cr as on 31-Mar-24
The share price of Dishman Carbogen Amcis Ltd is ₹195.68 (NSE) and ₹195.60 (BSE) as of 13-Aug-2024 IST. Dishman Carbogen Amcis Ltd has given a return of -1.72% in the last 3 years.
Dishman Carbogen Amcis Ltd has a market capitalisation of ₹ 3,067 Cr as on 13-Aug-2024. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Dishman Carbogen Amcis Ltd is 0.54 times as on 13-Aug-2024, a 47% discount to its peers’ median range of 1.02 times.
Since, TTM earnings of Dishman Carbogen Amcis Ltd is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Dishman Carbogen Amcis Ltd and enter the required number of quantities and click on buy to purchase the shares of Dishman Carbogen Amcis Ltd.
Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry in India and internationally. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, active pharmaceutical ingredients, phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D products, fine chemicals, hand and body wash, sanitizers, antiseptics, vitamin D analogues, cholesterol, lanolin-related products, disinfectant formulations, and various pharmaceutical and cosmetic-related products, as well as generic and highly potent active pharmaceutical ingredients. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited operates as a subsidiary of Adimans Technologies LLP.
The promoter of Dishman Carbogen Amcis Ltd is Adimans Technologies LLP. Adimans Technologies LLP owns 59.32 per cent of the total equity. The chairman of the company is Janmejay R Vyas , and the managing director is Arpit J Vyas..
There is no promoter pledging in Dishman Carbogen Amcis Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
452
|
|
|
289
|
|
|
132
|
|
|
58
|
| Dishman Carbogen Amcis Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
-2.56
|
|
Operating margin(%)
|
-0.93
|
|
Net Margin(%)
|
-5.8
|
|
Dividend yield(%)
|
0
|
No, TTM profit after tax of Dishman Carbogen Amcis Ltd was ₹-153 Cr.
No Review & Analysis are available.
₹3,066.68 Cr
₹2,615.77 Cr
₹-153.45 Cr
₹436.64 Cr
₹1,824.51 Cr
59.32%
High
₹133.00 - 283.00
₹2.00
15,67,83,095
BSE: 540701, NSE: DCAL
Ahmedabad, Gujarat
www.dishmangroup.com
Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry in India and internationally. The company operates through Contract Research and Manufacturing Services and Marketable Molecules... segments. It also manufactures and supplies bulk drugs, active pharmaceutical ingredients, phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D products, fine chemicals, hand and body wash, sanitizers, antiseptics, vitamin D analogues, cholesterol, lanolin-related products, disinfectant formulations, and various pharmaceutical and cosmetic-related products, as well as generic and highly potent active pharmaceutical ingredients. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited operates as a subsidiary of Adimans Technologies LLP. Read more
Stocks 
Dishman Carbogen Amcis Ltd.
Widely used:
